Prisys is a CRO company, pioneering in non-human primate (NHP) pharmacology, to provide peri-clinical studies of new drug development. Prisys integrated its proprietary modeling expertise and rich pharmacology experience with top-equipped local clinical hospitals, enabling global pharms to access the latest innovational approaches for more translatable and more efficient advancement of new therapeutics. With the huge unmet needs for more clinical relevance and predictions of human-target specific novel therapeutic strategies, Prisys has been continually developing different NHP models covering the following key disease areas: • Inflammatory • Autoimmune • Cardiovascular • Cerebrovascular • Hematology • Kidney • Liver • Lung • Ophthalmology • OB-GYN • Oncology Contact us at : info@prisysbiotech.com For more information please visit Website: www.prisysbiotech.com
View Top Employees from Prisys BiotechnologiesWebsite | http://www.prisysbiotech.com |
Revenue | $3 million |
Employees | 31 (25 on RocketReach) |
Founded | 2011 |
Phone | +86 21 5043 5616 |
Technologies |
JavaScript,
HTML,
Font Awesome
+8 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Business Services |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 541713 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies |
Looking for a particular Prisys Biotechnologies employee's phone or email?
The Prisys Biotechnologies annual revenue was $3 million in 2024.
Kevin Zhang is the Chief Scientific Officer of Prisys Biotechnologies.
25 people are employed at Prisys Biotechnologies.
The NAICS codes for Prisys Biotechnologies are [541713, 54171, 54, 541, 5417].
The SIC codes for Prisys Biotechnologies are [873, 87].